| Quarterly Financials | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 268 | 206 | 411 | 361 | 363 | 478 | 417 | 398 | 388 | 501 | 588 | 569 | 581 | 609 | 655 | 609 | 638 | 693 | 782 | 790 | 812 | 879 | 965 | 1,003 | 1,087 |
| Expenses | 203 | 165 | 268 | 268 | 258 | 330 | 283 | 264 | 259 | 358 | 412 | 411 | 413 | 449 | 475 | 459 | 475 | 509 | 559 | 585 | 599 | 679 | 757 | 799 | 879 |
| EBITDA | 65 | 40 | 143 | 93 | 105 | 148 | 134 | 134 | 129 | 143 | 177 | 158 | 168 | 160 | 180 | 150 | 163 | 184 | 223 | 205 | 213 | 200 | 208 | 204 | 208 |
| Operating Profit % | 24 % | 18 % | 34 % | 26 % | 28 % | 30 % | 31 % | 33 % | 31 % | 28 % | 27 % | 27 % | 28 % | 26 % | 27 % | 24 % | 25 % | 26 % | 28 % | 24 % | 25 % | 22 % | 21 % | 20 % | 18 % |
| Depreciation | 17 | 17 | 16 | 20 | 17 | 17 | 18 | 19 | 19 | 29 | 31 | 33 | 35 | 32 | 33 | 35 | 46 | 39 | 41 | 45 | 53 | 53 | 66 | 79 | 85 |
| Interest | 10 | 9 | 7 | 9 | 7 | 6 | 3 | 3 | 4 | 6 | 8 | 12 | 5 | 9 | 9 | 12 | 16 | 18 | 20 | 26 | 27 | 33 | 45 | 57 | 68 |
| Profit Before Tax | 38 | 14 | 120 | 65 | 81 | 125 | 113 | 112 | 107 | 107 | 138 | 113 | 127 | 119 | 139 | 102 | 100 | 127 | 162 | 135 | 134 | 114 | 97 | 69 | 55 |
| Tax | 10 | 5 | 29 | 17 | 22 | 33 | 29 | 28 | 24 | 28 | 31 | 31 | 29 | 32 | 37 | 26 | 29 | 32 | 42 | 42 | 28 | 29 | 25 | 17 | 22 |
| Net Profit | 28 | 9 | 90 | 48 | 59 | 92 | 84 | 84 | 83 | 79 | 106 | 82 | 99 | 87 | 101 | 77 | 72 | 95 | 121 | 93 | 106 | 85 | 72 | 52 | 33 |
| EPS in ₹ | 3.72 | 1.49 | 11.21 | 6.55 | 7.72 | 11.48 | 10.34 | 10.14 | 10.08 | 8.74 | 12.14 | 9.49 | 11.65 | 10.10 | 11.50 | 8.98 | 8.18 | 10.82 | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 | 1.06 |
Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences
769.30
+1.55
(0.20%)
Market Cap
30,782.69 Cr
PE Ratio
126.90
Volume
80,309.00
Day High - Low
773.75 - 753.65
52W High-Low
798.40 - 575.80
Key Fundamentals
Market Cap
30,782.69 Cr
EPS
6.03
PE Ratio
126.90
PB Ratio
13.67
Book Value
56.17
EBITDA
790.80
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
17.15
Debt to Equity
0.99
Analyst Rating and Forecast
- By Refinitiv from13 analysts
Actual
Company News
View All News
KIMS schedules investor meetings
6 days ago
6 days agoKrishna Institute of Medical Sciences will hold analyst meetings from May 25 to May 29, 2026. Discussions will focus on public domain business outlook.
KIMS Q4 Net Profit Falls to 425M Rupees YoYMay 16, 2026
Krishna Institute of Medical Sciences reports Q4 consolidated net profit of 425M rupees, down from 1.02B rupees YoY, while revenue rises to 10.7B rupees from 7.97B rupees.
Krishna Institute of Medical Sciences appoints new CFO, Company Secretary, Chief Risk Officer, and Cost Auditors; re-designates Adwik Bollineni as Executive Director effective May 15, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,189.50 | #1 1,17,752.44 | 59.30 | #1 25,228.50 | 14.70 | #1 2,032 | 33.00 | 63.72 | |
985.65 | 95,917.06 | 67.05 | 8,373.45 | 16.56 | 1,464 | 7.27 | 42.55 | |
959.85 | 72,464.66 | 68.55 | 9,127.84 | 16.28 | 1,064 | 44.26 | 59.54 | |
752.35 | 38,980.84 | 91.98 | 4,643.22 | 8.32 | 384 | #1 79.65 | 62.10 | |
1,892.00 | 38,665.06 | 47.95 | 7,896.04 | #1 41.63 | 788 | 13.53 | 56.07 | |
1,221.10 | 32,821.99 | 59.59 | 4,410.27 | 16.94 | 584 | 39.64 | 61.14 | |
769.30 | #7 30,782.69 | #10 126.90 | #7 3,904.60 | #2 27.31 | #9 198 | #10 -68.80 | 61.17 | |
484.75 | 15,357.24 | 90.43 | 2,080.08 | 18.39 | 168 | 17.65 | 65.17 | |
1,350.20 | 13,712.52 | 49.27 | 1,703.08 | 8.69 | 262 | 38.41 | 67.78 | |
286.18 | 12,361.00 | #1 45.42 | 1,679.36 | 17.77 | 272 | 46.56 | 77.79 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
27.31 %
Net Income Growth
-52.34 %
Cash Flow Change
11.65 %
ROE
6.85 %
ROCE
-11.21 %
EBITDA Margin (Avg.)
-24.35 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 958 | 1,118 | 1,196 | 1,436 | 1,907 | 2,941 | 3,852 | 5,736 | 7,759 |
| Fixed Assets | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,349 | 5,978 |
| Current Assets | 156 | 174 | 220 | 451 | 393 | 478 | 547 | 697 | 937 |
| Capital Work in Progress | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 | 606 |
| Investments | 0 | 0 | 0 | 0 | 333 | 68 | 157 | 99 | 97 |
| Other Assets | 203 | 254 | 278 | 496 | 549 | 630 | 660 | 1,075 | 0 |
| Total Equity & Liabilities | 958 | 1,118 | 1,196 | 1,436 | 1,907 | 2,941 | 3,852 | 5,736 | 7,759 |
| Current Liabilities | 749 | 201 | 219 | 278 | 215 | 297 | 452 | 836 | 1,239 |
| Non Current Liabilities | 347 | 351 | 366 | 282 | 282 | 707 | 1,307 | 2,481 | 3,961 |
| Total Equity | -138 | 566 | 611 | 876 | 1,411 | 1,938 | 2,093 | 2,419 | 2,247 |
| Reserve & Surplus | -209 | 466 | 523 | 786 | 1,307 | 1,590 | 1,748 | 2,058 | 2,167 |
| Share Capital | 50 | 75 | 75 | 78 | 80 | 80 | 80 | 80 | 80 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 5 | -11 | 5 | 3 | -3 | 33 | 12 | -27 | 36 | -15 | 9 |
| Investing Activities | -71 | -41 | -100 | -64 | -110 | -125 | -354 | -412 | -416 | -753 | -1,116 |
| Operating Activities | 64 | 95 | 82 | 106 | 134 | 202 | 356 | 324 | 432 | 521 | 582 |
| Financing Activities | 12 | -66 | 24 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.82 % | 38.82 % | 38.82 % | 38.82 % | 38.82 % | 38.82 % | 34.11 % | 34.11 % | 34.11 % | 34.11 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 8.61 % | 8.61 % | 0.00 % | 14.25 % | 0.00 % | 16.73 % | 17.84 % | 15.85 % | 15.68 % | 15.45 % | 15.54 % | 15.03 % | 14.33 % | 14.57 % |
| DIIs | 13.81 % | 16.11 % | 18.35 % | 18.49 % | 20.46 % | 27.98 % | 28.32 % | 29.76 % | 33.03 % | 34.80 % | 31.63 % | 33.13 % | 32.12 % | 32.30 % | 32.05 % | 31.95 % | 31.66 % | 32.12 % | 32.71 % | 32.50 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.14 % | 14.23 % | 13.38 % | 12.88 % | 11.81 % | 11.50 % | 11.32 % | 11.10 % | 11.22 % | 11.15 % | 10.84 % | 10.73 % | 10.61 % | 10.55 % | 10.97 % | 11.24 % | 11.58 % | 11.72 % | 11.76 % | 11.84 % |
| Others | 34.21 % | 30.82 % | 29.42 % | 29.79 % | 28.88 % | 21.68 % | 12.92 % | 11.69 % | 16.91 % | 0.96 % | 18.70 % | 0.59 % | 0.61 % | 2.48 % | 2.48 % | 2.54 % | 7.11 % | 7.03 % | 7.09 % | 6.98 % |
| No of Share Holders | 0 | 267 | 86,389 | 74,355 | 73,664 | 70,795 | 67,735 | 60,980 | 65,449 | 66,957 | 71,014 | 69,092 | 69,063 | 77,617 | 95,468 | 1,01,895 | 1,08,955 | 1,04,872 | 1,01,599 | 93,333 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Aug 2026 |  Annual General Meeting | NA | 27 Aug 2026 | 761.60 | 767.75 |
| 29 Aug 2024 | Annual General Meeting | NA | 29 Aug 2024 | 389.93 | 502.38 |
| 28 Jun 2024 |  Split | 2:10 | 13 Sept 2024 | 420.62 | 420.62 |
| 09 Nov 2024 |  Quarterly Result Announcement | NA | 09 Nov 2024 | 520.35 | 570.15 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 606.05 | 649.15 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 657.35 | 635.00 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 763.85 | 741.05 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 635.00 | 737.40 |
| 07 Nov 2025 | Quarterly Result Announcement | NA | 07 Nov 2025 | 720.20 | 720.15 |
| 06 Feb 2026 | Quarterly Result Announcement | NA | 06 Feb 2026 | 593.55 | 606.45 |
| 15 May 2026 | Quarterly Result Announcement | NA | 15 May 2026 | 675.95 | 773.30 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Change in ManagementMay 15, 2026
May 15, 2026ResultsMay 15, 2026
May 15, 2026Board Meeting Outcome for OutcomeMay 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2026
May 12, 2026Intimation Of Entering Into A Long-Term Lease Agreement For 2 Acres Of Land For A Period Of 60 Years In Amaravati Andhra Pradesh.May 08, 2026
May 08, 2026Board Meeting Intimation for Board Meeting Intimation.May 06, 2026
May 06, 2026Intimation Of Entering Into Memorandum Of Understanding For Strategic Clinical CollaborationApr 23, 2026
Apr 23, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 17, 2026
Apr 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Apr 13, 2026Pursuant To Provisions Of Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 KIMS Swastha Private Limited (The KIMS) A Wholly-Owned Subsidiary Of Krishna Institute Of Medical ScieApr 02, 2026
Apr 02, 2026The Subsidiary Company Has Received An Order Under Section 143(3) Read With Sections 250 And 144B Of The Income-Tax Act In Which The Department Has Set Aside The Said Demand Notice And Accordingly The Amount Payable In Respect Of This Matter Is Rs.0/- (ZeMar 31, 2026
Mar 31, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 17, 2026
Mar 17, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 14, 2026
Mar 14, 2026Board Meeting Outcome for Outcome Of Board MeetingMar 11, 2026
Mar 11, 2026Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On 11Th March 2026.Mar 06, 2026
Mar 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Feb 09, 2026General UpdateFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-AcquisitionFeb 06, 2026
Feb 06, 2026Q3FY26Feb 06, 2026
Feb 06, 2026Board Meeting Outcome for Outcome Of Board MeetingFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Feb 04, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Feb 02, 2026Board Meeting Intimation for The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 03Rd Quarter And Nine-Months Ended December 31 2025.Feb 02, 2026
Feb 02, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Jan 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 03, 2026
Jan 03, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 02, 2026
Jan 02, 2026Receipt Of Demand Order From GST Department By SPANV MEDISEARCH LIFESCIENCES PRIVATE LIMITED (Subsidiary Company).Jan 01, 2026
Jan 01, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Krishna Institute Of Medical Sciences Limited (The Company) Has Entered Into A Leave And License Agreement With Andhra Mahila Sabha For Taking Land Admeasuring Approximately 1.168 Acres (Equivalent To 21.19 Grounds) Located At Dr. Durgabai Deshmukh Road RDec 21, 2025
Dec 21, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 19, 2025
Dec 19, 2025Commencement Of Operations At PES University Campus In Electronic City BengaluruDec 15, 2025
Dec 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 13, 2025
Dec 13, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 61.17
ATR(14)
Less Volatile 27.95
STOCH(9,6)
Neutral 61.32
STOCH RSI(14)
Neutral 31.69
MACD(12,26)
Bullish 1.06
ADX(14)
Strong Trend 30.40
UO(9)
Bearish 57.52
ROC(12)
Uptrend But Slowing Down 6.99
WillR(14)
Neutral -25.76
About Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences Limited (KIMS) is an Indian healthcare company operating 12 multispecialty hospitals under the KIMS Hospitals brand. With over 4,000 beds, KIMS provides tertiary and quaternary healthcare services across more than 40 specialties and super specialties. The company's network includes hospitals in Telangana, Andhra Pradesh, and...more
Listing Date
28 Jun, 2021(4 Years,
29 days)
Chairperson NameBhaskara Rao Bollineni
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
